Compositions for the treatment of male erectile dysfunction

Compositions for the treatment of male erectile dysfunction

  • CN 1,338,939 B
  • Filed: 09/17/1999
  • Issued: 07/04/2012
  • Est. Priority Date: 09/17/1998
  • Status: Active Grant
First Claim
Patent Images

1. be used to treat the pharmaceutical composition of erection problem;

  • Wherein in buffer, contain pharmaceutical agent (1) phentolamine mesylate (2) Alprostadil and (3) papaverine hydrochlorate;

    Wherein said buffer contains weight ratio 1;

    20 L-arginine and glycine;

    And pH is 3 to 5, and wherein the dosage of phentolamine mesylate, papaverine hydrochlorate and Alprostadil is 1-5mg/ml phentolamine, 7.5-30mg/ml papaverine and 5-20 μ

    g/ml Alprostadil.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×